Your cancer is personal. Your questions should be too.
Patients increasingly receive large amounts of clinical and genomic information. The difficult part is understanding what matters, what is actionable, what remains uncertain, and what questions should be taken to the treating team.
Situations where this helps
Most cancer care follows well-established pathways, and for most patients that is exactly right. These are the situations where it is worth asking a second set of questions.
A rare cancer, where the evidence base is small
Relapsed cancer, where the biology may have changed
Progressive disease despite current treatment
Treatment resistance that is not yet explained
Complex genomic results that are hard to interpret
Multiple treatment options with no clear basis for choosing
Uncertain biomarkers whose relevance is unclear
A second opinion before a significant decision
Questions about whether a relevant clinical trial exists
Hereditary cancer concerns affecting your family
Cancer of unknown primary, where the origin is unresolved
- Clinical history and how the disease has behaved
- Pathology reports
- Imaging reports
- Molecular and genomic reports
- Somatic genomics
- Germline genetics
- ctDNA results
- Biomarkers
- Previous therapy
- Documented treatment response
- The relevant scientific evidence
- Clinical trial landscape
- A structured summary of your case as the documents describe it
- Interpretation of the molecular findings in clinical context
- A synthesis of the relevant evidence, including where it is thin
- Potentially relevant biomarkers
- Potential clinical-trial avenues
- A framework for the discussion ahead
- Specific questions to take to your treating doctors
- Monitoring considerations where relevant
What happens next
Three pages covering the process, the paperwork and what changes if you are outside India.
Which service applies
Most patients start with a consultation or a molecular report review. The others tend to follow from what that first review finds.
Precision Oncology Consultation
Molecular Report Review
Cancer Second Opinion
Precision Oncology Analysis & Strategy
Molecular Tumour Board Review
Clinical Trial Matching
Request a precision oncology review
Start with a short message describing the situation. What documentation is needed is agreed from there.